These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
320 related articles for article (PubMed ID: 28840558)
1. The Power of Zebrafish in Personalised Medicine. Baxendale S; van Eeden F; Wilkinson R Adv Exp Med Biol; 2017; 1007():179-197. PubMed ID: 28840558 [TBL] [Abstract][Full Text] [Related]
2. Recent progress in the use of zebrafish for novel cardiac drug discovery. Keßler M; Rottbauer W; Just S Expert Opin Drug Discov; 2015; 10(11):1231-41. PubMed ID: 26294375 [TBL] [Abstract][Full Text] [Related]
3. The Use of the Zebrafish Model to Aid in Drug Discovery and Target Validation. Yoganantharjah P; Gibert Y Curr Top Med Chem; 2017; 17(18):2041-2055. PubMed ID: 28137236 [TBL] [Abstract][Full Text] [Related]
4. Zebrafish as a Model Organism for the Development of Drugs for Skin Cancer. Bootorabi F; Manouchehri H; Changizi R; Barker H; Palazzo E; Saltari A; Parikka M; Pincelli C; Aspatwar A Int J Mol Sci; 2017 Jul; 18(7):. PubMed ID: 28718799 [TBL] [Abstract][Full Text] [Related]
5. Genomic editing opens new avenues for zebrafish as a model for neurodegeneration. Schmid B; Haass C J Neurochem; 2013 Nov; 127(4):461-70. PubMed ID: 24117801 [TBL] [Abstract][Full Text] [Related]
6. The zebrafish: a powerful platform for in vivo, HTS drug discovery. Delvecchio C; Tiefenbach J; Krause HM Assay Drug Dev Technol; 2011 Aug; 9(4):354-61. PubMed ID: 21309713 [TBL] [Abstract][Full Text] [Related]
7. High-Throughput Automated Chemical Screens in Zebrafish. Saydmohammed M; Tsang M Methods Mol Biol; 2018; 1683():383-393. PubMed ID: 29082504 [TBL] [Abstract][Full Text] [Related]
8. Zebrafish Is a Powerful Tool for Precision Medicine Approaches to Neurological Disorders. Ochenkowska K; Herold A; Samarut É Front Mol Neurosci; 2022; 15():944693. PubMed ID: 35875659 [TBL] [Abstract][Full Text] [Related]
9. One step forward: the use of transgenic zebrafish tumor model in drug screens. Huang X; Nguyen AT; Li Z; Emelyanov A; Parinov S; Gong Z Birth Defects Res C Embryo Today; 2011 Jun; 93(2):173-81. PubMed ID: 21671356 [TBL] [Abstract][Full Text] [Related]
10. Streamlining drug discovery assays for cardiovascular disease using zebrafish. Pott A; Rottbauer W; Just S Expert Opin Drug Discov; 2020 Jan; 15(1):27-37. PubMed ID: 31570020 [No Abstract] [Full Text] [Related]
11. In vivo zebrafish assays for analyzing drug toxicity. Raldúa D; Piña B Expert Opin Drug Metab Toxicol; 2014 May; 10(5):685-97. PubMed ID: 24617455 [TBL] [Abstract][Full Text] [Related]
12. CRISPR/Cas9 in zebrafish: an efficient combination for human genetic diseases modeling. Liu J; Zhou Y; Qi X; Chen J; Chen W; Qiu G; Wu Z; Wu N Hum Genet; 2017 Jan; 136(1):1-12. PubMed ID: 27807677 [TBL] [Abstract][Full Text] [Related]
13. Zebrafish models of cardiovascular diseases and their applications in herbal medicine research. Seto SW; Kiat H; Lee SM; Bensoussan A; Sun YT; Hoi MP; Chang D Eur J Pharmacol; 2015 Dec; 768():77-86. PubMed ID: 26494630 [TBL] [Abstract][Full Text] [Related]
14. Screening drugs for myocardial disease in vivo with zebrafish: an expert update. Zhao Y; Zhang K; Sips P; MacRae CA Expert Opin Drug Discov; 2019 Apr; 14(4):343-353. PubMed ID: 30836799 [TBL] [Abstract][Full Text] [Related]
15. Modulation of Threat Response in Larval Zebrafish. Rennekamp AJ Methods Mol Biol; 2018; 1787():147-159. PubMed ID: 29736716 [TBL] [Abstract][Full Text] [Related]
16. A Perspective on the Future of High-Throughput RNAi Screening: Will CRISPR Cut Out the Competition or Can RNAi Help Guide the Way? Taylor J; Woodcock S J Biomol Screen; 2015 Sep; 20(8):1040-51. PubMed ID: 26048892 [TBL] [Abstract][Full Text] [Related]
17. Applications of genome editing tools in precision medicine research. Li S; Yang YY; Qiu Y; Chen Y; Xu LW; Ding QR Yi Chuan; 2017 Mar; 39(3):177-188. PubMed ID: 28420614 [TBL] [Abstract][Full Text] [Related]